The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
- PMID: 17241619
- DOI: 10.1016/j.cbi.2006.12.003
The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
Abstract
Although they have several important limitations primary human hepatocytes still represent the in vitro gold standard model for xenobiotic metabolism and toxicity studies. The large use of human liver cell lines either from tumoral origin or obtained by oncogenic immortalisation is prevented by the loss of various liver-specific functions, especially many cytochrome P450 (CYP)-related enzyme activities. We review here recent results obtained with a new human hepatoma cell line, named HepaRG, derived from a human hepatocellular carcinoma. These cells exhibit unique features: when seeded at low density they acquire an elongated undifferentiated morphology, actively divided and after having reached confluency formed typical hepatocyte-like colonies surrounded by biliary epithelial-like cells. Moreover contrary to other human hepatoma cell lines including HepG2 cells, HepaRG cells express various CYPs (CYP1A2, 2B6, 2C9, 2E1, 3A4) and the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR) at levels comparable to those found in cultured primary human hepatocytes. They also express various other functions such phase 2 enzymes, apical and canalicular ABC transporters and basolateral solute carrier transporters, albumin, haptoglobin as well as aldolase B that is a specific marker of adult hepatocytes. HepaRG cells could represent a surrogate to primary human hepatocytes for xenobiotic metabolism and toxicity studies and even more, a unique model system for analysing genotoxic compounds.
Similar articles
-
Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.Drug Metab Dispos. 2006 Jan;34(1):75-83. doi: 10.1124/dmd.105.006759. Epub 2005 Oct 4. Drug Metab Dispos. 2006. PMID: 16204462
-
Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.Toxicol In Vitro. 2007 Dec;21(8):1581-91. doi: 10.1016/j.tiv.2007.05.014. Epub 2007 Jun 8. Toxicol In Vitro. 2007. PMID: 17637504
-
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.Drug Metab Dispos. 2010 Mar;38(3):516-25. doi: 10.1124/dmd.109.030197. Epub 2009 Dec 17. Drug Metab Dispos. 2010. PMID: 20019244
-
[New perspectives in the use of human hepatocytes in the preclinical drug development process].Ann Pharm Fr. 2008 Nov-Dec;66(5-6):288-95. doi: 10.1016/j.pharma.2008.09.002. Epub 2008 Oct 31. Ann Pharm Fr. 2008. PMID: 19061728 Review. French.
-
Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.Biochem Pharmacol. 2009 Feb 15;77(4):689-99. doi: 10.1016/j.bcp.2008.05.020. Epub 2008 Jul 5. Biochem Pharmacol. 2009. PMID: 18606396 Review.
Cited by
-
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection.Viruses. 2020 Aug 4;12(8):851. doi: 10.3390/v12080851. Viruses. 2020. PMID: 32759756 Free PMC article. Review.
-
A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity.Arch Toxicol. 2017 Mar;91(3):1385-1400. doi: 10.1007/s00204-016-1745-4. Epub 2016 Jun 25. Arch Toxicol. 2017. PMID: 27344343 Free PMC article.
-
Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells.Proteome Sci. 2012 Aug 2;10(1):47. doi: 10.1186/1477-5956-10-47. Proteome Sci. 2012. PMID: 22857383 Free PMC article.
-
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.Int J Mol Sci. 2021 Apr 27;22(9):4557. doi: 10.3390/ijms22094557. Int J Mol Sci. 2021. PMID: 33925355 Free PMC article. Review.
-
Rational deuteration of dronedarone attenuates its toxicity in human hepatic HepG2 cells.Toxicol Res (Camb). 2022 Mar 28;11(2):311-324. doi: 10.1093/toxres/tfac017. eCollection 2022 Apr. Toxicol Res (Camb). 2022. PMID: 35510231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials